Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

X5 Retail Group may buy Saratov's Grozd chain stores

5/11/23 FIVE

MTS reported for 3 months of 2023 by RAS

5/11/23 MTSS

Beyond Meat reports 3 months of 2023

5/11/23 BYND

Walt Disney reported 6 months of fiscal year 2023

5/11/23 DIS

Rosseti will receive from state shares of regional power grid company RPG

5/11/23 FEES

Seligdar reported for 3 months of 2023 by RAS

5/10/23 SELG

Rusolovo reported for 3 months of 2023 by RAS

5/10/23 ROLO

LSR wants to sell several plots in the south of St. Petersburg

5/10/23 LSRG

Natura Siberica plans to expand its store network by 30% by the summer of 2024

5/10/23 AFKS

Consortium of investors buys Syneos Health

5/10/23 SYNH